Rijhul Lahariya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rijhul Lahariya has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Gargee Anand
Department of Microbiology, All India Institute of Medical Sciences, Patna, India
6 shared publications - Mainak Sinha
Department of General Surgery, All India Institute of Medical Sciences, Patna, Bihar India
5 shared publications Gargee Anand
4 shared publicationsBandana Kumari
Department of Biochemistry, All India Institute of Medical Sciences, Patna, Bihar, India, 801507
3 shared publications- Bandana Kumari
Department of Biochemistry, All India Institute of Medical Sciences, Patna, India
3 shared publications - Anand Kumar Das
Department of Neurosurgery, All India Institute of Medical Sciences, Patna, Bihar, India
2 shared publications
Latest Publications
- 16 October 2026
- Published by Springer Nature in Wiener Medizinische Wochenschrift
- p. 1-12
Device-Associated Sepsis and Brain Injury: Transitioning From Early Infection Control to Late Neuroprotection
Summary Sepsis-associated encephalopathy (SAE) is a complex neuroinflammatory condition characterized by diffuse brain dysfunction arising from systemic infection without direct central nervous system invasion. In modern critical care, device-associated infections (DAIs) caused by invasive medical devices, such as central line-associated bloodstream infections, ventilator-associated pneumonia, and catheter-associated urinary tract infections, have become critical drivers of intensive care unit (ICU)-acquired sepsis. Biofilm formation on these devices establishes persistent inflammatory reservoirs that continuously shed microorganisms, pathogen-associated molecular patterns (PAMPs), and damage-associated molecular patterns (DAMPs) into the circulation, sustaining systemic immune activation. This review outlines an integrated mechanistic framework linking DAIs to acute brain dysfunction. Systemic inflammation and endothelial activation trigger microvascular dysfunction, impaired cerebral autoregulation, and blood–brain barrier disruption. These peripheral vascular alterations allow inflammatory mediators to access the central nervous system, where they induce microglial and astrocytic reactivity. Persistent neuroimmune activation compromises neurotransmitter homeostasis—causing glutamate excitotoxicity and cholinergic deficits—while impairing neuronal mitochondrial oxidative phosphorylation. The resulting oxidative stress, energy failure, and self-amplifying neuroinflammatory feedback loops culminate in synaptic damage and neuronal injury. Clinically, this manifests as altered consciousness, delirium, seizures, and long-term neurocognitive impairment. By framing SAE as a concurrent, multidimensional continuum rather than a linear sequence, this review highlights the critical role of early infection prevention, timely device removal, and targeted neuroprotective strategies aimed at stabilizing vascular integrity and mitigating neuroinflammation.
- 16 October 2026
- Published by Springer Nature in Wiener Medizinische Wochenschrift
- p. 1-12
Device-Associated Sepsis and Brain Injury: Transitioning From Early Infection Control to Late Neuroprotection
Summary Sepsis-associated encephalopathy (SAE) is a complex neuroinflammatory condition characterized by diffuse brain dysfunction arising from systemic infection without direct central nervous system invasion. In modern critical care, device-associated infections (DAIs) caused by invasive medical devices, such as central line-associated bloodstream infections, ventilator-associated pneumonia, and catheter-associated urinary tract infections, have become critical drivers of intensive care unit (ICU)-acquired sepsis. Biofilm formation on these devices establishes persistent inflammatory reservoirs that continuously shed microorganisms, pathogen-associated molecular patterns (PAMPs), and damage-associated molecular patterns (DAMPs) into the circulation, sustaining systemic immune activation. This review outlines an integrated mechanistic framework linking DAIs to acute brain dysfunction. Systemic inflammation and endothelial activation trigger microvascular dysfunction, impaired cerebral autoregulation, and blood–brain barrier disruption. These peripheral vascular alterations allow inflammatory mediators to access the central nervous system, where they induce microglial and astrocytic reactivity. Persistent neuroimmune activation compromises neurotransmitter homeostasis—causing glutamate excitotoxicity and cholinergic deficits—while impairing neuronal mitochondrial oxidative phosphorylation. The resulting oxidative stress, energy failure, and self-amplifying neuroinflammatory feedback loops culminate in synaptic damage and neuronal injury. Clinically, this manifests as altered consciousness, delirium, seizures, and long-term neurocognitive impairment. By framing SAE as a concurrent, multidimensional continuum rather than a linear sequence, this review highlights the critical role of early infection prevention, timely device removal, and targeted neuroprotective strategies aimed at stabilizing vascular integrity and mitigating neuroinflammation.
- 30 June 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1)
Overcoming resistance in glioblastoma immunotherapy: lessons from the past and opportunities for the future
Glioblastoma (GBM) is the most aggressive primary brain tumor in adults, characterized by rapid proliferation, diffuse invasion, and profound therapeutic resistance, leading to a median survival of approximately 15 months despite maximal treatment. Immunotherapy, which has transformed outcomes in other malignancies, has shown limited success in GBM due to its immune-privileged environment, extensive immunosuppressive networks, and tumor heterogeneity. Clinical trials of checkpoint inhibitors, cancer vaccines, CAR-T cells, oncolytic viruses, and microenvironment-targeting agents have largely failed to produce durable survival benefits, often hindered by poor T-cell infiltration, antigen loss, and redundant suppressive mechanisms within the tumor microenvironment. Lessons from these failures highlight the necessity of mechanism-informed strategies that address the tumor's immune evasion. Next-generation approaches emphasize priming the tumor to enhance immune visibility, targeting multiple antigens to prevent escape, optimizing locoregional CAR-T delivery, using oncolytic viruses as immune catalysts rather than sole cytotoxic agents, and strategically modulating the microenvironment to support effector responses. By integrating these insights, rational combination strategies can transform GBM immunotherapy from incremental efficacy to meaningful clinical benefit. Translational rigor, adaptive trial designs, and biology-driven interventions are essential to overcoming the complex barriers posed by GBM and achieving durable anti-tumor immunity.
- 30 June 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1)
Overcoming resistance in glioblastoma immunotherapy: lessons from the past and opportunities for the future
Glioblastoma (GBM) is the most aggressive primary brain tumor in adults, characterized by rapid proliferation, diffuse invasion, and profound therapeutic resistance, leading to a median survival of approximately 15 months despite maximal treatment. Immunotherapy, which has transformed outcomes in other malignancies, has shown limited success in GBM due to its immune-privileged environment, extensive immunosuppressive networks, and tumor heterogeneity. Clinical trials of checkpoint inhibitors, cancer vaccines, CAR-T cells, oncolytic viruses, and microenvironment-targeting agents have largely failed to produce durable survival benefits, often hindered by poor T-cell infiltration, antigen loss, and redundant suppressive mechanisms within the tumor microenvironment. Lessons from these failures highlight the necessity of mechanism-informed strategies that address the tumor's immune evasion. Next-generation approaches emphasize priming the tumor to enhance immune visibility, targeting multiple antigens to prevent escape, optimizing locoregional CAR-T delivery, using oncolytic viruses as immune catalysts rather than sole cytotoxic agents, and strategically modulating the microenvironment to support effector responses. By integrating these insights, rational combination strategies can transform GBM immunotherapy from incremental efficacy to meaningful clinical benefit. Translational rigor, adaptive trial designs, and biology-driven interventions are essential to overcoming the complex barriers posed by GBM and achieving durable anti-tumor immunity.
- Open Access
- 12 June 2026
- Published by AccScience Publishing in Innovative Medicines & Omics
- p. 026180020
Neuroinflammation and tumor microenvironment remodeling in brain tumors: Cellular interactions, immunometabolic adaptations, and therapeutic perspectives
Brain tumors remain among the most aggressive and therapeutically challenging malignancies due to their highly complex and immunosuppressive tumor microenvironment. Increasing evidence suggests that neuroinflammation plays a central role in tumor initiation, progression, angiogenesis, immune evasion, therapeutic resistance, and tumor recurrence. This review discusses the multifaceted role of neuroinflammatory signaling in primary and secondary brain tumors, with emphasis on the dynamic interactions between tumor cells, microglia, tumor-associated macrophages, neutrophils, dendritic cells, lymphocytes, and stromal components within the tumor microenvironment. Particular focus is placed on inflammatory cytokines and signaling pathways, including interleukin (IL)-6, tumor necrosis factor-alpha, transforming growth factor beta, programmed cell death protein 1/programmed death-ligand 1 (PD-1/PD-L1), nuclear factor kappa-light-chain-enhancer of activated B cells, signal transducer and activator of transcription 3, and hypoxia-associated hypoxia-inducible factor 1-alpha signaling, which collectively contribute to immunosuppression and tumor progression. The review further highlights the importance of metabolic adaptation, hypoxia-driven remodeling, oxidative stress, and immune exhaustion in shaping the inflammatory landscape of central nervous system tumors. Emerging evidence regarding nicotinamide adenine dinucleotide phosphate oxidases (NADPH oxidase 2 [NOX2], NOX4, and NOX5) and reactive oxygen species-mediated therapeutic resistance, particularly temozolomide resistance in glioblastoma, is also discussed. In addition, clinically relevant inflammatory biomarkers such as CD163+ tumor-associated macrophages, neutrophil-to-lymphocyte ratio, PD-L1 expression, and isocitrate dehydrogenase-associated immune phenotypes are examined for their potential prognostic and therapeutic significance. Recent advances in therapeutic strategies targeting neuroinflammation, including colony-stimulating factor 1 receptor inhibitors, IL-6 pathway blockade, immune checkpoint modulation, anti-angiogenic therapy, and tumor microenvironment reprogramming approaches, are reviewed along with their current translational limitations. Overall, this review provides an integrative overview of the relationship between neuroinflammation and tumor microenvironment remodeling in brain tumors and highlights the growing potential of biomarker-guided and microenvironment-directed therapeutic strategies in neuro-oncology.
- 12 June 2026
- Published by AccScience Publishing in Innovative Medicines & Omics
- p. 026180020
Open AccessNeuroinflammation and tumor microenvironment remodeling in brain tumors: Cellular interactions, immunometabolic adaptations, and therapeutic perspectives
Brain tumors remain among the most aggressive and therapeutically challenging malignancies due to their highly complex and immunosuppressive tumor microenvironment. Increasing evidence suggests that neuroinflammation plays a central role in tumor initiation, progression, angiogenesis, immune evasion, therapeutic resistance, and tumor recurrence. This review discusses the multifaceted role of neuroinflammatory signaling in primary and secondary brain tumors, with emphasis on the dynamic interactions between tumor cells, microglia, tumor-associated macrophages, neutrophils, dendritic cells, lymphocytes, and stromal components within the tumor microenvironment. Particular focus is placed on inflammatory cytokines and signaling pathways, including interleukin (IL)-6, tumor necrosis factor-alpha, transforming growth factor beta, programmed cell death protein 1/programmed death-ligand 1 (PD-1/PD-L1), nuclear factor kappa-light-chain-enhancer of activated B cells, signal transducer and activator of transcription 3, and hypoxia-associated hypoxia-inducible factor 1-alpha signaling, which collectively contribute to immunosuppression and tumor progression. The review further highlights the importance of metabolic adaptation, hypoxia-driven remodeling, oxidative stress, and immune exhaustion in shaping the inflammatory landscape of central nervous system tumors. Emerging evidence regarding nicotinamide adenine dinucleotide phosphate oxidases (NADPH oxidase 2 [NOX2], NOX4, and NOX5) and reactive oxygen species-mediated therapeutic resistance, particularly temozolomide resistance in glioblastoma, is also discussed. In addition, clinically relevant inflammatory biomarkers such as CD163+ tumor-associated macrophages, neutrophil-to-lymphocyte ratio, PD-L1 expression, and isocitrate dehydrogenase-associated immune phenotypes are examined for their potential prognostic and therapeutic significance. Recent advances in therapeutic strategies targeting neuroinflammation, including colony-stimulating factor 1 receptor inhibitors, IL-6 pathway blockade, immune checkpoint modulation, anti-angiogenic therapy, and tumor microenvironment reprogramming approaches, are reviewed along with their current translational limitations. Overall, this review provides an integrative overview of the relationship between neuroinflammation and tumor microenvironment remodeling in brain tumors and highlights the growing potential of biomarker-guided and microenvironment-directed therapeutic strategies in neuro-oncology.
- Top Cited Papers
- 10 February 2026
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 136 (6) , 733-744
Time-dependent neurovascular unit dysfunction in ischemic stroke: mechanisms of neurovascular uncoupling and its clinical impact
Neurovascular unit (NVU) dysfunction is a central determinant of tissue injury, reperfusion failure, and long-term neurological outcomes after ischemic stroke. This review critically examines the cellular and molecular mechanisms underlying NVU disruption, with a particular focus on inflammation, oxidative stress, and blood-brain barrier (BBB) integrity, and evaluates emerging NVU-targeted therapeutic strategies. A focused narrative review synthesized studies on ischemic stroke-related NVU alterations, integrating cellular mechanisms, biomarkers, and phase-specific therapeutic strategies targeting BBB dysfunction, inflammation, oxidative stress, and neurorestoration. Acute ischemic injury induces endothelial tight-junction disruption, pericyte constriction and loss, astrocytic activation, and microglial-driven inflammation, resulting in BBB breakdown, impaired neurovascular coupling, and restricted microvascular reperfusion. These processes facilitate leukocyte infiltration, exacerbate secondary neuronal damage, and increase hemorrhagic transformation risk. Circulating and cerebrospinal fluid biomarkers, including MMP-9, GFAP, S100B, and pro-inflammatory cytokines, reflect NVU injury severity and correlate with functional outcomes. In the chronic phase, persistent BBB permeability, maladaptive VEGF signaling, and sustained low-grade inflammation contribute to white matter injury, impaired neuroplasticity, and post-stroke cognitive decline. Therapeutic strategies targeting NVU dysfunction include anti-inflammatory agents, COX-2 inhibitors, and NADPH oxidase inhibitors, alongside stem cell-based and extracellular vesicle-mediated approaches that promote vascular stabilization and repair. Neuroplasticity-enhancing interventions and nanoparticle-based drug delivery systems further support functional recovery. NVU dysfunction underlies both acute injury amplification and chronic recovery failure after stroke. Biomarker-guided, phase-specific therapeutic strategies targeting inflammation, oxidative stress, and BBB instability represent a promising framework for personalized stroke management.
- 10 February 2026
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 136 (6) , 733-744
Top Cited PapersTime-dependent neurovascular unit dysfunction in ischemic stroke: mechanisms of neurovascular uncoupling and its clinical impact
Neurovascular unit (NVU) dysfunction is a central determinant of tissue injury, reperfusion failure, and long-term neurological outcomes after ischemic stroke. This review critically examines the cellular and molecular mechanisms underlying NVU disruption, with a particular focus on inflammation, oxidative stress, and blood-brain barrier (BBB) integrity, and evaluates emerging NVU-targeted therapeutic strategies. A focused narrative review synthesized studies on ischemic stroke-related NVU alterations, integrating cellular mechanisms, biomarkers, and phase-specific therapeutic strategies targeting BBB dysfunction, inflammation, oxidative stress, and neurorestoration. Acute ischemic injury induces endothelial tight-junction disruption, pericyte constriction and loss, astrocytic activation, and microglial-driven inflammation, resulting in BBB breakdown, impaired neurovascular coupling, and restricted microvascular reperfusion. These processes facilitate leukocyte infiltration, exacerbate secondary neuronal damage, and increase hemorrhagic transformation risk. Circulating and cerebrospinal fluid biomarkers, including MMP-9, GFAP, S100B, and pro-inflammatory cytokines, reflect NVU injury severity and correlate with functional outcomes. In the chronic phase, persistent BBB permeability, maladaptive VEGF signaling, and sustained low-grade inflammation contribute to white matter injury, impaired neuroplasticity, and post-stroke cognitive decline. Therapeutic strategies targeting NVU dysfunction include anti-inflammatory agents, COX-2 inhibitors, and NADPH oxidase inhibitors, alongside stem cell-based and extracellular vesicle-mediated approaches that promote vascular stabilization and repair. Neuroplasticity-enhancing interventions and nanoparticle-based drug delivery systems further support functional recovery. NVU dysfunction underlies both acute injury amplification and chronic recovery failure after stroke. Biomarker-guided, phase-specific therapeutic strategies targeting inflammation, oxidative stress, and BBB instability represent a promising framework for personalized stroke management.
- Open Access
- 28 January 2026
- Published by Georg Thieme Verlag KG in Asian Journal of Neurosurgery
- Vol. 21 (02) , 291-300
Influence of Early Exposure and Educational Gaps on Medical Students: A Career-Driven Strategy for Aspiring Neurosurgeons
Neurosurgery is a high-demand specialty in medicine, yet the factors influencing medical students' decision to pursue it remain underexplored. This study aimed to evaluate the demographics, academic year-wise interest, motivating and deterring factors, and the role of undergraduate exposure in influencing students' intentions to pursue neurosurgery. A cross-sectional survey of 503 Bachelor of Medicine, Bachelor of Surgery (MBBS) students across India was conducted. The survey assessed demographics, academic year, interest in neurosurgery, motivating and deterring factors, and perceptions of neurosurgical exposure during undergraduate education. Statistical analyses, including chi-square and multinomial logistic regression, were applied to determine significant associations between variables. The study revealed that interest in neurosurgery was highest among first- and second-year students, with a sharp decline observed by the internship year. Primary motivators included personal interest in neuroscience and the prestige of the field. Significant deterrents were limited exposure to neurosurgery and concerns about work-life balance. A gender disparity was found, with males showing greater interest in neurosurgery, mirroring national trends in the specialty. Half of the respondents believed that neurosurgery was underrepresented in the MBBS curriculum, and most supported its inclusion as a mandatory subject. Additionally, students expressed a preference for practicing neurosurgery in India, citing familial and financial considerations as key factors. The findings emphasize the importance of early exposure, mentorship, and curriculum improvements in shaping students' career decisions. Addressing regional and gender disparities, alongside ensuring robust neurosurgical training, is essential for fostering a motivated, diverse workforce in the field of neurosurgery. R.L., S.K.S., and M.S. contributed to the conception and design of this article. M.S., A.K.D., and R.L. were responsible for the methodology and initial draft preparation. Literature search and data collection were conducted by R.L. and M.S.. The final draft was written by R.L. and M. S.. All authors reviewed, revised, and approved the final manuscript. R.L. and M.S. contributed equally to this work. Both S.K.S. and A.K.D. are corresponding authors. * Both authors contributed equally to this work. Article published online: 28 January 2026 © 2026. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
- 28 January 2026
- Published by Georg Thieme Verlag KG in Asian Journal of Neurosurgery
- Vol. 21 (02) , 291-300
Open AccessInfluence of Early Exposure and Educational Gaps on Medical Students: A Career-Driven Strategy for Aspiring Neurosurgeons
Neurosurgery is a high-demand specialty in medicine, yet the factors influencing medical students' decision to pursue it remain underexplored. This study aimed to evaluate the demographics, academic year-wise interest, motivating and deterring factors, and the role of undergraduate exposure in influencing students' intentions to pursue neurosurgery. A cross-sectional survey of 503 Bachelor of Medicine, Bachelor of Surgery (MBBS) students across India was conducted. The survey assessed demographics, academic year, interest in neurosurgery, motivating and deterring factors, and perceptions of neurosurgical exposure during undergraduate education. Statistical analyses, including chi-square and multinomial logistic regression, were applied to determine significant associations between variables. The study revealed that interest in neurosurgery was highest among first- and second-year students, with a sharp decline observed by the internship year. Primary motivators included personal interest in neuroscience and the prestige of the field. Significant deterrents were limited exposure to neurosurgery and concerns about work-life balance. A gender disparity was found, with males showing greater interest in neurosurgery, mirroring national trends in the specialty. Half of the respondents believed that neurosurgery was underrepresented in the MBBS curriculum, and most supported its inclusion as a mandatory subject. Additionally, students expressed a preference for practicing neurosurgery in India, citing familial and financial considerations as key factors. The findings emphasize the importance of early exposure, mentorship, and curriculum improvements in shaping students' career decisions. Addressing regional and gender disparities, alongside ensuring robust neurosurgical training, is essential for fostering a motivated, diverse workforce in the field of neurosurgery. R.L., S.K.S., and M.S. contributed to the conception and design of this article. M.S., A.K.D., and R.L. were responsible for the methodology and initial draft preparation. Literature search and data collection were conducted by R.L. and M.S.. The final draft was written by R.L. and M. S.. All authors reviewed, revised, and approved the final manuscript. R.L. and M.S. contributed equally to this work. Both S.K.S. and A.K.D. are corresponding authors. * Both authors contributed equally to this work. Article published online: 28 January 2026 © 2026. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
- Top Cited Papers
- 20 January 2026
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 413, 578870
Postbiotics and the gut–brain axis: A mechanistic review on modulating neuroinflammation and cognitive aging
- 20 January 2026
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 413, 578870
Top Cited PapersPostbiotics and the gut–brain axis: A mechanistic review on modulating neuroinflammation and cognitive aging
- Top Cited Papers
- 2 January 2026
- Published by Springer Nature in Hernia
- Vol. 30 (1) , 47
SurgiCut-AI: an AI-driven tool for predicting surgical site infections following ventral hernia repair using pre- and intra-operative parameters
Purpose Surgical Site Infection (SSI) is the common consequence of hernia surgery. This study aimed to develop an artificial intelligence (AI)-driven predictive model for SSI following open ventral hernia repair using pre- and intra-operative parameters for early detection. Methods A prospective analysis of ventral hernia patients was conducted. Demographic, pre-operative and intra-operative parameters were collected. Feature selection using Recursive Feature Elimination (RFE) identified key predictors. Five models, eXtreme Gradient Boosting (XGBoost), logistic regression, support vector machine (SVM), Adaptive Boosting and random forest (RF), were trained and validated. Results Among 253 patients, 22 were SSI-positive. RF demonstrated the highest predictive power (area under receiver operating characteristic curve = 0.82) and diagnostic odds ratio (DOR = 55). Seven key predictors were identified: defect size area, HbA1c, lymphocytes, neutrophil-to-lymphocyte ratio, blood loss (ml), platelet count and serum albumin. Decision curve analysis showed an estimated risk stratification at an 8.3% cutoff “https://surgicut-ai.netlify.app/”. Conclusion The model’s high accuracy supports its potential for clinical decision-making. External validation is required for real-world application. Integrating this AI model into bedside tools may enhance SSI prevention, especially in resource-limited settings.
- 2 January 2026
- Published by Springer Nature in Hernia
- Vol. 30 (1) , 47
Top Cited PapersSurgiCut-AI: an AI-driven tool for predicting surgical site infections following ventral hernia repair using pre- and intra-operative parameters
Purpose Surgical Site Infection (SSI) is the common consequence of hernia surgery. This study aimed to develop an artificial intelligence (AI)-driven predictive model for SSI following open ventral hernia repair using pre- and intra-operative parameters for early detection. Methods A prospective analysis of ventral hernia patients was conducted. Demographic, pre-operative and intra-operative parameters were collected. Feature selection using Recursive Feature Elimination (RFE) identified key predictors. Five models, eXtreme Gradient Boosting (XGBoost), logistic regression, support vector machine (SVM), Adaptive Boosting and random forest (RF), were trained and validated. Results Among 253 patients, 22 were SSI-positive. RF demonstrated the highest predictive power (area under receiver operating characteristic curve = 0.82) and diagnostic odds ratio (DOR = 55). Seven key predictors were identified: defect size area, HbA1c, lymphocytes, neutrophil-to-lymphocyte ratio, blood loss (ml), platelet count and serum albumin. Decision curve analysis showed an estimated risk stratification at an 8.3% cutoff “https://surgicut-ai.netlify.app/”. Conclusion The model’s high accuracy supports its potential for clinical decision-making. External validation is required for real-world application. Integrating this AI model into bedside tools may enhance SSI prevention, especially in resource-limited settings.
- 1 December 2025
- Published by Springer Nature in Current Microbiology
- Vol. 83 (1) , 47
Bloodstream Infection-induced Neuroinflammation: from Systemic Infection To Brain Invasion
Bloodstream infections (BSIs), caused by a diverse array of microbial pathogens, have emerged as key drivers of systemic inflammation that can compromise the integrity of blood-brain barrier (BBB) and trigger neuroinflammatory responses. This review highlights the pivotal role of BSIs in initiating neuroinflammation and accelerating the progression of neurodegenerative diseases (NDDs). Literature review shows that pathogens involved in BSIs can disrupt the BBB, activate neuroglial cells, and release pro-inflammatory cytokines, ultimately causing neuronal injury and fueling chronic neuroinflammation. Clinically, survivors of BSIs, especially those who experience sepsis, face a heightened risk of long-term neurological decline. While antimicrobial treatments remain essential, advanced therapeutic options such as psychedelics, immunomodulators, and nano pharmacology, gene therapies offer promising strategies to mitigate neuroinflammation and protect brain function. The review emphasizes the urgency of early intervention, particularly in sepsis patients, to prevent the onset of chronic NDDs and preserve cognitive health. A deeper understanding of the mechanisms underlying BSI-induced neuroinflammation will be critical in developing personalized treatments to reduce the neurological burden associated with these infections. Ultimately, this review aims to provide clinicians with insights into neuroprotective strategies that have shown promise in animal models of BSIs, with the potential to improve patient outcomes if validated in humans; further clinical studies are essential to translate these findings into effective therapies for long-term neurological consequences.
- 1 December 2025
- Published by Springer Nature in Current Microbiology
- Vol. 83 (1) , 47
Bloodstream Infection-induced Neuroinflammation: from Systemic Infection To Brain Invasion
Bloodstream infections (BSIs), caused by a diverse array of microbial pathogens, have emerged as key drivers of systemic inflammation that can compromise the integrity of blood-brain barrier (BBB) and trigger neuroinflammatory responses. This review highlights the pivotal role of BSIs in initiating neuroinflammation and accelerating the progression of neurodegenerative diseases (NDDs). Literature review shows that pathogens involved in BSIs can disrupt the BBB, activate neuroglial cells, and release pro-inflammatory cytokines, ultimately causing neuronal injury and fueling chronic neuroinflammation. Clinically, survivors of BSIs, especially those who experience sepsis, face a heightened risk of long-term neurological decline. While antimicrobial treatments remain essential, advanced therapeutic options such as psychedelics, immunomodulators, and nano pharmacology, gene therapies offer promising strategies to mitigate neuroinflammation and protect brain function. The review emphasizes the urgency of early intervention, particularly in sepsis patients, to prevent the onset of chronic NDDs and preserve cognitive health. A deeper understanding of the mechanisms underlying BSI-induced neuroinflammation will be critical in developing personalized treatments to reduce the neurological burden associated with these infections. Ultimately, this review aims to provide clinicians with insights into neuroprotective strategies that have shown promise in animal models of BSIs, with the potential to improve patient outcomes if validated in humans; further clinical studies are essential to translate these findings into effective therapies for long-term neurological consequences.